MedTrace Logo

Convection Enhanced Delivery of CSF in DBS for Parkinson's

NCT03540134 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2021-04-08

Study results available
· View outcomes & findings →

Summary

This study will evaluate safety foremost but also the distribution and initial effectiveness of infusion-enhanced, MRI-guided DBS for patients with medication-refractory, Parkinson's disease

Conditions

  • Parkinson Disease

Interventions

DEVICE

Intracerebral Infusion of Autologous Cerebral Spinal Fluid

Unilateral infusion of 0.5 ml autologous CSF before DBS electrode insertion with MRI monitoring

Sponsors & Collaborators

  • Jeff Elias, MD

    lead OTHER

Principal Investigators

  • William J Elias, MD · University of Virginia

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-13
Primary Completion
2018-12-18
Completion
2018-12-18
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03540134 on ClinicalTrials.gov